KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Restructuring Costs (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed Restructuring Costs for 13 consecutive years, with $84.0 million as the latest value for Q4 2025.

  • Quarterly Restructuring Costs rose 100.0% to $84.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $228.0 million through Dec 2025, down 2.56% year-over-year, with the annual reading at $228.0 million for FY2025, 2.56% down from the prior year.
  • Restructuring Costs hit $84.0 million in Q4 2025 for Johnson & Johnson, up from $63.0 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $164.0 million in Q1 2024 to a low of -$13.0 million in Q2 2024.
  • Historically, Restructuring Costs has averaged $75.3 million across 5 years, with a median of $63.5 million in 2025.
  • Biggest five-year swings in Restructuring Costs: plummeted 108.97% in 2024 and later soared 592.31% in 2025.
  • Year by year, Restructuring Costs stood at $60.0 million in 2021, then rose by 8.33% to $65.0 million in 2022, then fell by 13.85% to $56.0 million in 2023, then dropped by 25.0% to $42.0 million in 2024, then surged by 100.0% to $84.0 million in 2025.
  • Business Quant data shows Restructuring Costs for JNJ at $84.0 million in Q4 2025, $63.0 million in Q3 2025, and $64.0 million in Q2 2025.